Commure

Command Your Tech, Empower Your People

Mountain View, United States · Founded 2017 · $1.2B raised

Employees
501–1000
Founded
2017
Business Model
B2B
Total Funding
$1.2B
Last Round
$70.0M Series FMay 2026
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Commure is an AI-native healthcare operating system formed from the 2023 merger of Athelas and Commure, automating the full revenue cycle from patient intake through clinical documentation, coding, claims, and payment. The platform integrates with 60+ EHRs, serves 150+ health systems across 2,000 sites of care, and processes $25B+ in annual claims and 40M+ ambient appointments annually. Valued at $6B and named to the 2025 Fortune Future 50, Commure is backed by General Catalyst, Sequoia, NVIDIA, and Y Combinator.

Summary

Commure is an Artificial Intelligence company based in Mountain View, United States, founded in 2017. It has raised $1.2B in total across 7 rounds, most recently a $70.0M Series F round in May 2026. Investors include General Catalyst, Human Capital and Greenoaks Capital.

Tech & App Stack

13 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series FSeries FMay 2026
$70.0M

Sign up to see all 7 events

Funding: Seed through Series F. Amounts, valuations, and investors where available.

Investors

Brands

Similar Companies

Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Commure on Indexed.vc
<a href="https://indexed.vc/companies/commure"><img src="https://indexed.vc/api/badge/company/commure" alt="Commure on Indexed.vc" width="260" height="76" /></a>